重新思考癌症临床试验在 COVID-19 及以后的应用。
Rethinking cancer clinical trials for COVID-19 and beyond.
机构信息
Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
出版信息
Nat Cancer. 2020 Jun;1(6):568-572. doi: 10.1038/s43018-020-0083-x.
The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care.
当前 COVID-19 大流行给癌症患者带来的风险要求医疗服务迅速进行结构性改革，其中许多积极的变化可能会长期持续。基于临床和科学优先事项，对试验方法进行紧急批判性重新评估对于确保临床癌症研究的弹性和优化以患者为中心的护理至关重要。
Zotero 插件